For context, the same quality concerns apply when choosing a compounding pharmacy for GLP-1 medications
Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
Research highlights that a small percentage of women taking semaglutide experience menstrual changes
The Stubborn Weight Battler: Women frustrated by lingering weight gain, especially around the midsection, despite efforts to eat better and stay active
First approved to treat type 2 diabetes, GLP-1 based drugs are now used to aid weight loss in obesity and to help lower the risk of heart failure and treat obstructive sleep apnea, a common breathing-related sleep disorder, in people with obesity
Reconstitute and handle in accordance with standard laboratory safety protocols